Gemma Rogers, Communications Director at Oxford PharmaGenesis, discusses the paper, ‘Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment’, published in BMJ Evidence-Based Medicine.
Recorded 21 October 2019 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv
Gemma’s presentation (PDF format) is available here.
Categories